Amy C Gladstein

6PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 10, 2025
Primary tumor chromatin landscape governs metastatic organotropism.

Amy C Gladstein, David M Feldser

|Jun 12, 2025
The H3 K36M oncohistone inhibits NSD2 to activate a SETD2-dependent antiviral-like immune response in KRAS-driven lung cancer.

Amy C Gladstein, Carson D Poltorack, Akino Mercy Charles Solomon

|Sep 20, 2023
Metastatic Competency and Tumor Spheroid Formation Are Independent Cell States Governed by RB in Lung Adenocarcinoma.

Nelson F Freeburg, Nia Peterson, Dain A Ruiz

|Jul 21, 2023
p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism.

Jonuelle Acosta, Qinglan Li, Nelson F Freeburg

|Mar 10, 2023
Setd2 inactivation sensitizes lung adenocarcinoma to inhibitors of oxidative respiration and mTORC1 signaling.

David M Walter, Amy C Gladstein, Katherine R Doerig

Pageof 1